PortfoliosLab logo
PPH vs. XPH
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Correlation

The correlation between PPH and XPH is 0.68, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


Performance

PPH vs. XPH - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in VanEck Vectors Pharmaceutical ETF (PPH) and SPDR S&P Pharmaceuticals ETF (XPH). The values are adjusted to include any dividend payments, if applicable.

Loading data...

Key characteristics

Sharpe Ratio

PPH:

0.04

XPH:

0.12

Sortino Ratio

PPH:

0.18

XPH:

0.29

Omega Ratio

PPH:

1.02

XPH:

1.04

Calmar Ratio

PPH:

0.05

XPH:

0.06

Martin Ratio

PPH:

0.10

XPH:

0.25

Ulcer Index

PPH:

8.26%

XPH:

8.73%

Daily Std Dev

PPH:

16.43%

XPH:

21.56%

Max Drawdown

PPH:

-46.49%

XPH:

-48.03%

Current Drawdown

PPH:

-10.19%

XPH:

-28.99%

Returns By Period

In the year-to-date period, PPH achieves a 2.57% return, which is significantly higher than XPH's -5.32% return. Over the past 10 years, PPH has outperformed XPH with an annualized return of 3.85%, while XPH has yielded a comparatively lower -2.66% annualized return.


PPH

YTD

2.57%

1M

-1.64%

6M

-1.36%

1Y

0.57%

3Y*

5.53%

5Y*

8.78%

10Y*

3.85%

XPH

YTD

-5.32%

1M

-1.58%

6M

-11.57%

1Y

2.65%

3Y*

0.30%

5Y*

-0.04%

10Y*

-2.66%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


VanEck Vectors Pharmaceutical ETF

SPDR S&P Pharmaceuticals ETF

PPH vs. XPH - Expense Ratio Comparison

PPH has a 0.36% expense ratio, which is higher than XPH's 0.35% expense ratio.


Go deeper with the Portfolio Analysis tool — backtest performance, assess risk, compare to benchmarks, and more

Risk-Adjusted Performance

PPH vs. XPH — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

PPH
The Risk-Adjusted Performance Rank of PPH is 1717
Overall Rank
The Sharpe Ratio Rank of PPH is 1616
Sharpe Ratio Rank
The Sortino Ratio Rank of PPH is 1616
Sortino Ratio Rank
The Omega Ratio Rank of PPH is 1616
Omega Ratio Rank
The Calmar Ratio Rank of PPH is 1818
Calmar Ratio Rank
The Martin Ratio Rank of PPH is 1717
Martin Ratio Rank

XPH
The Risk-Adjusted Performance Rank of XPH is 1919
Overall Rank
The Sharpe Ratio Rank of XPH is 1919
Sharpe Ratio Rank
The Sortino Ratio Rank of XPH is 1919
Sortino Ratio Rank
The Omega Ratio Rank of XPH is 1919
Omega Ratio Rank
The Calmar Ratio Rank of XPH is 1919
Calmar Ratio Rank
The Martin Ratio Rank of XPH is 1919
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

PPH vs. XPH - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for VanEck Vectors Pharmaceutical ETF (PPH) and SPDR S&P Pharmaceuticals ETF (XPH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The current PPH Sharpe Ratio is 0.04, which is lower than the XPH Sharpe Ratio of 0.12. The chart below compares the historical Sharpe Ratios of PPH and XPH, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading data...

Go to the full Sharpe Ratio tool to analyze any stock or portfolio. Customize time frames, set your own risk-free rate, and more

Dividends

PPH vs. XPH - Dividend Comparison

PPH's dividend yield for the trailing twelve months is around 1.93%, more than XPH's 1.62% yield.


TTM20242023202220212020201920182017201620152014
PPH
VanEck Vectors Pharmaceutical ETF
1.93%1.98%2.09%1.55%1.62%1.66%1.77%1.97%1.92%2.43%1.93%1.71%
XPH
SPDR S&P Pharmaceuticals ETF
1.62%1.58%1.28%1.64%0.95%0.47%0.64%0.65%0.67%0.63%7.15%5.55%

Drawdowns

PPH vs. XPH - Drawdown Comparison

The maximum PPH drawdown since its inception was -46.49%, roughly equal to the maximum XPH drawdown of -48.03%. Use the drawdown chart below to compare losses from any high point for PPH and XPH.


Loading data...

Go to the full Drawdowns tool for more analysis options, including inflation-adjusted drawdowns, and more

Volatility

PPH vs. XPH - Volatility Comparison

VanEck Vectors Pharmaceutical ETF (PPH) and SPDR S&P Pharmaceuticals ETF (XPH) have volatilities of 7.50% and 7.61%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.


Loading data...